Foot dystonia as the only manifestation of unilateral nigral atrophy

Movement Disorders

Volumn 23, Issue 13, 2008, Pages 1951-1954

  Momjian Mayor, Isabelle ^a   Coeytaux, Alessandra ^a   Castillo, Veronica ^a   Nokatch, Natalia ^a   Delavelle, Jacqueline ^a   Burkhard, Pierre R ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; BOTULINUM TOXIN; ROPINIROLE; TRIHEXYPHENIDYL;

ADULT; ARTICLE; BRAIN ATROPHY; CASE REPORT; CLINICAL FEATURE; CLINICAL PROTOCOL; DISEASE ASSOCIATION; DYSTONIA; FEMALE; FOOT DYSTONIA; GAIT DISORDER; HUMAN; NEUROLOGIC EXAMINATION; NIGRONEOSTRIATAL SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOPLEGIA; PARALYSIS; PRIORITY JOURNAL; SYMPTOM; UNILATERAL NIGRAL ATROPHY; VIET NAM;

ADULT; ATROPHY; DYSTONIA; FEMALE; FOOT; FUNCTIONAL LATERALITY; HUMANS; MAGNETIC RESONANCE IMAGING; SUBSTANTIA NIGRA;

EID: 57049183585     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22109     Document Type: Article

References (20)

1. Marsden CD, Obeso JA, Sarranz JJ, Lang AE. The anatomical basis of symptomatic hemidystonia. Brain 1985;108:463-483.
2. Hartmann A, Pogarell O, Oertel WH. Secondary dystonias. J Neurol 1998;245:511-518.
3. Jentzer A, de Morsier G. Hémiparkinsonisme droit post-traumatique avec lésion du noyau rouge et du locus niger gauche. Etude anatomo-clinique. Swiss Arch Neurol Psychiatry 1947;60: 388-393.
4. Hardy RC, Stevenson LD. Syringomesencephalia. Report of a case with signs of Parkinson's disease having a syrinx of the substantia nigra. J Neuropathol Exp Neurol 1957;16:365-370.
5. Hunter R, Smith J, Thomson T, Dayan AD. Hemiparkinsonism with infarction of the ipsilateral substantia nigra. Neuropathol Appl Neurobiol 1978;4:297-301.
6. Cheshire WP, Ehle AL. Hemiparkinsonism as a complication of an Ommaya reservoir. J Neurosurg 1990;73:774-776.
7. de la Fuente Fernandez R, Marey Lopez J, Rey del Corral P, de la Iglesia Martinez F. Peduncular hallucinosis and right hemiparkinsonism caused by left mesencephalic infarction. J Neurol Neurosurg Psychiatry 1994;57:870.
8. Abe K, Yanagihara T. Hemiparkinsonism following haemorrhage in the contralateral substantia nigrfa. Neuroradiology 1996;38 (Suppl 1):S67-S69.
9. Peters S, Eising EG, Prfzuntek H, Müller T. Vascular parkinsonism: a case report and review of the literature. J Clin Neurosci 2001;8:268-271.
10. Yoshimura M, Yamamoto T, Iso-o N, et al. Hemiparkinsonism associated with a mesencephalic tumor. J Neurol Sci 2002;197: 89-92.
11. Morgan JC, Sethi KD. Midbrain infarct with parkinsonism. Neurology 2003;60:E10.
12. Orimo S, Amino T, Tanaka H, Mitani K, Ishiwata K, Ishii K. A case of hemiparkinsonism following ischemic lesion of the contralateral substantia nigra: a PET study. Eur Neurol 2004; 51:175-177.
13. Krause M, Hähnel S, Haberkorn U, Meinck HM. Dopa-responsive hemiparkinsonism due to midbrain Virchow-Robin spaces? J Neurol 2005;252:1555-1557.
14. Ruzicka E, Urgosik D, Jech R, et al. Hemiparkinsonism and levodopa-induced dyskinesia after focal nigral lesion. Mov Disord 2005;20:759-762.
15. Ohta K, Obara K. Hemiparkinsonism with a discrete lacunar infarction in the contralateral substantia nigra. Mov Disord 2006; 21:124-125.
16. Akyol A, Ogan Akyildiz U, Tataroglu C. Vascular parkinsonism: a case of lacunar infarction localized to mesencephalic substantia nigra. Parkinsonism Relat Disord 2006;12:459-461.
17. 18F]spiperone binding in putamen in idiopathic focal dystonia. J Neurosci 1997;17:843-850.
18. Vidailhet M, Dupel C, Lehéricy S, et al. Dopaminergic dysfunction in midbrain dystonia. Anatomoclinical study using 3-dimensional magnetic resonance imaging and fluorodopa F 18 positron emission tomography. Arch Neurol 1999;56:982-989.
19. Tackenberg B, Metz A, Unger M, et al. Nigrostriatal dysfunction in X-linked dystonia-parkinsonism (DYT3). Mov Disord 2007; 22:900-902.
20. Popolo M, McCarthy DM, Bhide PG. Influence of dopamine on precursor cell proliferation and differentiation in the embryonic mouse telencephalon. Dev Neurosci 2004;26:229-244.